{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:47:18Z","timestamp":1776185238761,"version":"3.50.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The most common causes of congenital neutropenia are mutations in the <jats:italic>ELANE<\/jats:italic> (Elastase, Neutrophil Expressed) gene (19p13.3), mostly in exon 5 and the distal portion of exon 4, which result in different clinical phenotypes of neutropenia. Here, we report two pathogenic mutations in <jats:italic>ELANE<\/jats:italic>, namely, c.607G&amp;gt;C (p.Gly203Arg) and a novel variant c.416C&amp;gt;G (p.Pro139Arg), found in two Mexican families ascertained via patients with congenital neutropenia who responded positively to the granulocyte colony-stimulating factor (G-CSF) treatment. These findings highlight the usefulness of identifying variants in patients with inborn errors of immunity for early clinical management and the need to rule out mosaicism in noncarrier parents with more than one case in the family.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1194262","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:32:47Z","timestamp":1695108767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Characterization of known (c.607G&gt;C) and novel (c.416C&gt;G) ELANE mutations in two Mexican families with congenital neutropenia"],"prefix":"10.3389","volume":"14","author":[{"given":"Mar\u00eda Enriqueta","family":"N\u00fa\u00f1ez-N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Lona-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"L\u00f3pez-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Margarita","family":"Cruz-Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bricia Melissa","family":"Guti\u00e9rrez-Zepeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Quintero-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisse Stephania","family":"Becerra-Loaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14887","article-title":"Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history","volume":"179","author":"Donadieu","year":"2017","journal-title":"Br J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653932","article-title":"Neutrophil elastase defects in congenital neutropenia","volume":"12","author":"Rydzynska","year":"2021","journal-title":"Front Immunol"},{"key":"B3","unstructured":"Baltimore, MDJohns Hopkins UniversityOnline Mendelian Inheritance in Man, OMIM"},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12887-019-1556-x","article-title":"Functional characteristics of circulating granulocytes in severe congenital neutropenia caused by ELANE mutations","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Pediatr"},{"key":"B5","unstructured":"Baltimore, MDJohns Hopkins UniversityOnline Mendelian Inheritance in Man, OMIM"},{"key":"B6","unstructured":"Baltimore, MDJohns Hopkins UniversityOnline Mendelian Inheritance in Man, OMIM"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537068","article-title":"Severe congenital neutropenia: new lane for ELANE","volume":"123","author":"Borregaard","year":"2014","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.04.007","article-title":"Neutrophil elastase: Nonsense lost in translation","volume":"28","author":"Horwitz","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2011.s2.e9","article-title":"Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML\/MDS","author":"Vandenberghe","year":"2011","journal-title":"Pediatr Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2011.26.12.1646","article-title":"Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia","volume":"26","author":"Shim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.983668","article-title":"De novo mutations, genetic mosaicism and human disease","volume":"26","author":"Mohiuddin","year":"2022","journal-title":"Front Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0580-1","article-title":"Mosaicism of an ELANE mutation in an asymptomatic mother","volume":"39","author":"Shigemura","year":"2019","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.04.008","article-title":"Two paternal mosaicism of mutation in ELANE causing severe congenital neutropenia exhibit normal neutrophil morphology and ROS production","volume":"203","author":"Liu","year":"2019","journal-title":"Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25654","article-title":"Paternal somatic mosaicism of a novel frameshift mutation in ELANE causing severe congenital neutropenia","volume":"62","author":"Kim","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0060","article-title":"Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia","volume":"100","author":"Ancliff","year":"2002","journal-title":"Blood"},{"key":"B16","unstructured":"ELANE2023"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2019.01.004","article-title":"Congenital neutropenia and rare functional phagocyte disorders in children","volume":"33","author":"Walkovich","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"B18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4419-7073-2_6","article-title":"Cyclic and chronic neutropenia","volume":"157","author":"Dale","year":"2011","journal-title":"Cancer Treat Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hoc.2012.10.004","article-title":"ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology","volume":"27","author":"Horwitz","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"B20","unstructured":"ELANE-Related neutropenia\n            DaleDC\n            MakaryanV\n          Seattle (WAUniversity of Washington, SeattleGeneReviews"},{"key":"B21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1053\/shem.2002.31917","article-title":"Cyclic neutropenia","volume":"39","author":"Dale","year":"2002","journal-title":"Semin Hematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19961230)66:4<413::AID-AJMG5>3.0.CO;2-L","article-title":"Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis","volume":"66","author":"Palmer","year":"1996","journal-title":"Am J Med Genet"},{"key":"B23","unstructured":"ClinVar; [VCV000016743.20]"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22308","article-title":"The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia","volume":"34","author":"Germeshausen","year":"2013","journal-title":"Hum Mutat"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23104","article-title":"Four novel ELANE mutations in patients with congenital neutropenia","volume":"57","author":"Kurnikova","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1630622","article-title":"Neutropenia and leukemia development: genetic risk factors and prognosis","volume":"60","author":"Shahrabi","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.12.013","article-title":"Hereditary predisposition to hematopoietic neoplasms: when bloodline matters for blood cancers","volume":"95","author":"Mangaonkar","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MOH.0000000000000479","article-title":"Mechanisms of leukemic transformation in congenital neutropenia","volume":"26","author":"Link","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4370","article-title":"Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","volume":"107","author":"Rosenberg","year":"2006","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"key":"B32","article-title":"Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy","volume":"96","author":"Freedman","year":"2000","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-406116","article-title":"Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia","volume":"119","author":"Beekman","year":"2012","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2741\/2103","article-title":"Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders","volume":"12","author":"Touw","year":"2007","journal-title":"Front Biosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2002.31912","article-title":"Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias","volume":"39","author":"Freedman","year":"2002","journal-title":"Semin Hematol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3518","article-title":"Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register","volume":"103","author":"Bellann\u00e9-Chantelot","year":"2004","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3356835","article-title":"In Silico analysis revealed five novel high-risk single-nucleotide polymorphisms (rs200384291, rs201163886, rs193141883, rs201139487, and rs201723157) in ELANE gene causing autosomal dominant severe congenital neutropenia 1 and cyclic hematopoiesis","volume":"2022","author":"Shinwari","year":"2022","journal-title":"ScientificWorldJournal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017665","article-title":"Digenic mutations in severe congenital neutropenia","volume":"95","author":"Germeshausen","year":"2010","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07866.x","article-title":"Double de novo mutations of ELANE (ELA2) in a patient with severe congenital neutropenia requiring high-dose G-CSF therapy","volume":"147","author":"Lund\u00e9n","year":"2009","journal-title":"Br J Haematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20529","article-title":"Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia","volume":"28","author":"Salipante","year":"2007","journal-title":"Hum Mutat"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22537","article-title":"Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes","volume":"55","author":"Newburger","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn760","article-title":"STRING 8\u2013a global view on proteins and their functional interactions in 630 organisms","volume":"37","author":"Jensen","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/35049558","article-title":"The origins, patterns and implications of human spontaneous mutation","volume":"1","author":"Crow","year":"2000","journal-title":"Nat Rev Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2022.03.018","article-title":"What is a variant of uncertain significance in genetic testing","volume":"8","author":"Nicolosi","year":"2022","journal-title":"Eur Urol Focus"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-018-0086-2","article-title":"Physician interpretation of variants of uncertain significance","volume":"18","author":"Macklin","year":"2019","journal-title":"Fam Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14818","article-title":"Approach to the patient with a variant of uncertain significance on genetic testing","volume":"97","author":"Newey","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12257","article-title":"A systematic approach to assessing the clinical significance of genetic variants","volume":"84","author":"Duzkale","year":"2013","journal-title":"Clin Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1194262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:32:49Z","timestamp":1695108769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1194262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2023.1194262"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1194262","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"article-number":"1194262"}}